The best travel mugs will keep your tea warm on a long journey and your chilled water cold. The best reusable coffee cups are a great sustainable option if you enjoy hot drinks, and while their ...
Learn more› By Kit Dillon and Wirecutter Staff As of December 2024, Stanley is recalling the Classic Trigger-Action mug, our pick for ... to help us put together some advice on how to prepare ...
Future of Healthcategory UK health system to offer cutting-edge gene therapy for sickle cell disease January 31, 2025 Future of Healthcategory US FDA approves Axsome Therapeutics' migraine drug ...
It recently received healthy beverage status under the U.S. FDA, making huge news particularly back in India where tea holds significant cultural space, and so there are innumerable studies ...
If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. For the first time in over two decades, the U.S. Food and Drug Administration (FDA) has ...
Axsome Therapeutics (AXSM) announced that the U.S. FDA has approved Symbravo for the acute treatment of migraine with or without aura in adults. Symbravo represents a novel multi-mechanistic ...
The US Food and Drug Administration signed off Thursday ... acting director of the FDA’s Center for Drug Evaluation and Research, said in a news release. “This action and the agency’s ...
After notching its highest sales in the US since 2019 last year, Mitsubishi intends to keep the momentum going with a revamped lineup, including its first electric vehicle. Mitsubishi told US ...
Let's take a look at the biotech stocks awaiting FDA decisions in February. Supernus Pharmaceuticals Inc. (SUPN) The FDA decision on Supernus Pharma's SPN-830, an investigational apomorphine ...
The US economy grew 2.5% over the past year, according to new Commerce Department figures released Thursday, comparing the fourth quarter in 2024 with the one from a year earlier. A resilient ...
In a letter to FDA Deputy Commissioner for Human Foods Jim Jones released Wednesday, Democratic Sens. Richard Blumenthal (Conn.), Tina Smith (Minn.), Cory Booker (N.J.) and Dick Durbin (Ill.) ...
Vertex has attracted interest from Wall Street for its ambitious drug pipeline that involves winning FDA approval for multiple drugs across several forms of chronic pain, which generally ...